295 related articles for article (PubMed ID: 12171070)
1. A novel plasma membrane quinone reductase and NAD(P)H:quinone oxidoreductase 1 are upregulated by serum withdrawal in human promyelocytic HL-60 cells.
Forthoffer N; Gómez-Díaz C; Bello RI; Burón MI; Martín SF; Rodríguez-Aguilera JC; Navas P; Villalba JM
J Bioenerg Biomembr; 2002 Jun; 34(3):209-19. PubMed ID: 12171070
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant response induced by serum withdrawal protects HL-60 cells against inhibition of NAD(P)H:quinone oxidoreductase 1.
Gómez-Díaz C; Bello RI; López-Lluch G; Forthoffer N; Navas P; Villalba JM
Biofactors; 2003; 18(1-4):219-28. PubMed ID: 14695937
[TBL] [Abstract][Full Text] [Related]
3. The reductive metabolism of diaziquone (AZQ) in the S9 fraction of MCF-7 cells: free radical formation and NAD(P)H: quinone-acceptor oxidoreductase (DT-diaphorase) activity.
Fisher GR; Gutierrez PL
Free Radic Biol Med; 1991; 10(6):359-70. PubMed ID: 1654286
[TBL] [Abstract][Full Text] [Related]
4. Quinoneimines as substrates for quinone reductase (NAD(P)H: (quinone-acceptor)oxidoreductase) and the effect of dicumarol on their cytotoxicity.
Powis G; See KL; Santone KS; Melder DC; Hodnett EM
Biochem Pharmacol; 1987 Aug; 36(15):2473-9. PubMed ID: 2440444
[TBL] [Abstract][Full Text] [Related]
5. Vitamin E and selenium deficiency induces expression of the ubiquinone-dependent antioxidant system at the plasma membrane.
Navarro F; Navas P; Burgess JR; Bello RI; De Cabo R; Arroyo A; Villalba JM
FASEB J; 1998 Dec; 12(15):1665-73. PubMed ID: 9837856
[TBL] [Abstract][Full Text] [Related]
6. The nature of DT-diaphorase (EC 1.6.99.2) activity in plasma membrane of astrocytes in primary cultures.
Malviya AN; Mandel P; Mersel M
Biochim Biophys Acta; 1986 Apr; 849(2):288-92. PubMed ID: 2421769
[TBL] [Abstract][Full Text] [Related]
7. NAD(P)H: quinone oxidoreductase (DT-diaphorase) in chick embryo liver. Comparison to activity in rat and guinea pig liver and differences in co-induction with 7-ethoxyresorufin deethylase by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Spencer CB; Rifkind AB
Biochem Pharmacol; 1990 Jan; 39(2):327-35. PubMed ID: 2105732
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of RH1 and related aziridinylbenzoquinones: involvement of activation by NAD(P)H:quinone oxidoreductase (NQO1) and oxidative stress.
Nemeikaite-Ceniene A; Sarlauskas J; Anusevicius Z; Nivinskas H; Cenas N
Arch Biochem Biophys; 2003 Aug; 416(1):110-8. PubMed ID: 12859987
[TBL] [Abstract][Full Text] [Related]
9. Expression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones.
Gustafson DL; Beall HD; Bolton EM; Ross D; Waldren CA
Mol Pharmacol; 1996 Oct; 50(4):728-35. PubMed ID: 8863816
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial NADH-quinone oxidoreductase of the outer membrane is responsible for paraquat cytotoxicity in rat livers.
Shimada H; Hirai K; Simamura E; Pan J
Arch Biochem Biophys; 1998 Mar; 351(1):75-81. PubMed ID: 9500851
[TBL] [Abstract][Full Text] [Related]
11. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S
Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528
[TBL] [Abstract][Full Text] [Related]
12. The role of NAD(P)H: quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9.
Walton MI; Smith PJ; Workman P
Cancer Commun; 1991 Jul; 3(7):199-206. PubMed ID: 1714284
[TBL] [Abstract][Full Text] [Related]
13. Treatment of pancreatic cancer cells with dicumarol induces cytotoxicity and oxidative stress.
Lewis A; Ough M; Li L; Hinkhouse MM; Ritchie JM; Spitz DR; Cullen JJ
Clin Cancer Res; 2004 Jul; 10(13):4550-8. PubMed ID: 15240547
[TBL] [Abstract][Full Text] [Related]
14. Histochemical detection of quinone reductase activity in situ using LY 83583 reduction and oxidation.
Murphy TH; So AP; Vincent SR
J Neurochem; 1998 May; 70(5):2156-64. PubMed ID: 9572303
[TBL] [Abstract][Full Text] [Related]
15. NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity.
Pink JJ; Planchon SM; Tagliarino C; Varnes ME; Siegel D; Boothman DA
J Biol Chem; 2000 Feb; 275(8):5416-24. PubMed ID: 10681517
[TBL] [Abstract][Full Text] [Related]
16. Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9.
Fitzsimmons SA; Workman P; Grever M; Paull K; Camalier R; Lewis AD
J Natl Cancer Inst; 1996 Mar; 88(5):259-69. PubMed ID: 8614004
[TBL] [Abstract][Full Text] [Related]
17. p-nitrosophenol reduction by liver cytosol from ADH-positive and -negative deermice (Peromyscus maniculatus).
Dudley BF; Winston GW
Arch Biochem Biophys; 1995 Feb; 316(2):879-85. PubMed ID: 7532387
[TBL] [Abstract][Full Text] [Related]
18. Sex-dependent activities of quinone reductases in rabbits indicate higher risk of bladder cancer in the male.
Mohandas J; Chennell AF; Duggin GG; Horvath JS; Tiller DJ
Carcinogenesis; 1986 Mar; 7(3):353-6. PubMed ID: 2419007
[TBL] [Abstract][Full Text] [Related]
19. Mitomycin C is not metabolized by but is an inhibitor of human kidney NAD(P)H: (quinone-acceptor)oxidoreductase.
Schlager JJ; Powis G
Cancer Chemother Pharmacol; 1988; 22(2):126-30. PubMed ID: 3136941
[TBL] [Abstract][Full Text] [Related]
20. Advances in research on DT-diaphorase--catalytic properties, regulation of activity and significance in the detoxication of foreign compounds.
Horie S
Kitasato Arch Exp Med; 1990 Apr; 63(1):11-30. PubMed ID: 2125671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
